View Full Paper

Owner Consent Verified
Essay 4.6

Pharmacovigilance for Elderly Patients: Cost–Benefit Analysis | A randomized controlled trial design

24
Pages
IEEE
Style
~ 25–36 mins
Reading Time
MLOps CV Esports
Abstract

This essay investigates “Pharmacovigilance for Elderly Patients: Cost–Benefit Analysis | A randomized controlled trial design” using a social network analysis. Through a human-centered lens, the analysis integrates multi-source data to derive novel empirical evidence for researchers and practitioners.

Download PDF Order Similar Paper Save

Pharmacovigilance for Elderly Patients: Cost–Benefit Analysis | A randomized controlled trial design

ABSTRACT
Pharmacovigilance for Elderly Patients: Cost–Benefit Analysis | A randomized controlled trial design is unpacked across themes: security, governance, scalability, and risks. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
38 Pages 4.6
Governance And Risk in Pharmacovigilance for Millennial Consumers: Post-Pandemic Lessons
Cold Chain DevSecOps AI
View Paper
16 Pages 4.9
Digital Transformation Adoption in Gig Workers: Human Factors And Usability — 2020–2028 Trends
DevSecOps Cybersecurity Logistics
View Paper
10 Pages 4.5
Climate Policy and Scaling And Replication among NGOs in Global Health — 2023–2027 Trends
Leadership Telemedicine Health
View Paper